|
Volumn 18, Issue 5, 2003, Pages 584-587
|
Mirtazapine in essential tremor: A double-blind, placebo-controlled pilot study
|
Author keywords
Double blind; Mirtazapine; Placebo; Tremor
|
Indexed keywords
ATENOLOL;
GABAPENTIN;
METOPROLOL;
MIRTAZAPINE;
PLACEBO;
PRIMIDONE;
PROPRANOLOL;
ADULT;
AGED;
ARTICLE;
BALANCE DISORDER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DEPRESSION;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DROWSINESS;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
DYSGEUSIA;
ESSENTIAL TREMOR;
FEMALE;
GAIT DISORDER;
HUMAN;
MALE;
NAUSEA;
NEUROLOGIC EXAMINATION;
PARKINSON DISEASE;
PILOT STUDY;
POLYURIA;
PRIORITY JOURNAL;
PRURITUS;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
SIDE EFFECT;
TREATMENT OUTCOME;
VISUAL IMPAIRMENT;
WEIGHT GAIN;
XEROSTOMIA;
AGED;
ANTIDEPRESSIVE AGENTS, TRICYCLIC;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
ESSENTIAL TREMOR;
FEMALE;
HUMANS;
MALE;
MIANSERIN;
OUTCOME ASSESSMENT (HEALTH CARE);
PSYCHOMOTOR PERFORMANCE;
QUESTIONNAIRES;
SEVERITY OF ILLNESS INDEX;
|
EID: 0038485934
PISSN: 08853185
EISSN: None
Source Type: Journal
DOI: 10.1002/mds.10371 Document Type: Article |
Times cited : (28)
|
References (8)
|